← Open Payments lookup

TODD ANTIN: Open Payments

NPI 1598714073 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$164,815 in 217 payments from 15 companies in 2025. Trend: 2023 $113,967 · 2024 $165,493 · 2025 $164,815

Speaker / faculty: $136,906Travel & lodging: $11,798Consulting: $11,798Food & beverage: $4,314
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.72$93,872
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)74$48,670
Vanda Pharmaceuticals Inc.27$14,427
E.R. Squibb & Sons, L.L.C.12$7,112
Otsuka America Pharmaceutical, Inc.7$156
Janssen Pharmaceuticals, Inc5$128
Neurocrine BioSciences, Inc.4$121
Axsome Therapeutics, Inc.4$79
ACADIA Pharmaceuticals Inc3$64
Collegium Pharmaceutical, Inc.3$61

Products named: AUSTEDO XR, CAPLYTA, UZEDY, FANAPT, COBENFY, REXULTI, INGREZZA, SPRAVATO.

Industry payments across GA — which companies pay providers there.